ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreKidney Disease Is Tougher on Men Than Women, and Researchers Now Know Why
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Women tend to be better able than men to recover from kidney injury, but why?Apparently women have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidn…
Learn MoreSecond, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Exposure to a second or third dose of COVID-19 vaccine is associated with an increased risk for relapse for adults with glomerular disease, according to a study published online Nov. 3 in the Journal of the Ame…
Learn MoreCKD Incidence Differs by Race in People With Diabetes
MONDAY, Nov. 7, 2022 (HealthDay News) — A high incidence of chronic kidney disease (CKD) persists among U.S. patients with diabetes, with differences seen across racial and ethnic groups, according to a letter to the editor published in the Oct. 13 i…
Learn MoreDapagliflozin May Be Cost-Effective for Treating CKD
FRIDAY, Nov. 4, 2022 (HealthDay News) — Dapagliflozin seems to be cost-effective in the United Kingdom, Germany, and Spain for patients meeting the eligibility criteria for the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Diseas…
Learn MorePsoriasis Not Tied to Myocardial Infarction in Patients With ESRD
TUESDAY, Nov. 1, 2022 (HealthDay News) — Among individuals with end-stage renal disease (ESRD), psoriasis is not associated with an increased risk for myocardial infarction (MI), according to a study recently published in the American Journal of the …
Learn MoreBenefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
TUESDAY, Nov. 1, 2022 (HealthDay News) — Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspiri…
Learn MoreTrajectories of CKD Symptoms May Predict Later Health Outcomes
MONDAY, Oct. 31, 2022 (HealthDay News) — Distinct trajectories of chronic kidney disease (CKD) may predict subsequent health outcomes, according to a study published online Oct. 28 in the Clinical Journal of the American Society of Nephrology.Moustap…
Learn MoreRegular Aerobic Exercise May Improve Chronic Kidney Disease Outcomes
TUESDAY, Oct. 25, 2022 (HealthDay News) — Regular aerobic exercise is associated with significant improvements in chronic kidney disease (CKD) measures, according to a systematic review and meta-analysis published online Sept. 26 in Frontiers in Phys…
Learn MoreFactors Linked to Self-Care Behavior ID’d for CKD Patients
THURSDAY, Oct. 20, 2022 (HealthDay News) — For patients with chronic kidney disease (CKD), promoting adequate self-care necessitates identification of each patient’s barriers and needs based on individual characteristics including age, cohabitation, …
Learn More